Intervention Review

You have free access to this content

Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever)

  1. Emmanuel E Effa1,*,
  2. Hasifa Bukirwa2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 5 OCT 2011

Assessed as up-to-date: 31 JUL 2008

DOI: 10.1002/14651858.CD006083.pub3

Database Title

Additional Information

How to Cite

Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No.: CD006083. DOI: 10.1002/14651858.CD006083.pub3.

Author Information

  1. 1

    University of Calabar Teaching Hospital, Internal Medicine, Calabar, Cross River State, Nigeria

  2. 2

    Makerere University Medical School, Kampala, Uganda

*Emmanuel E Effa, Internal Medicine, University of Calabar Teaching Hospital, PMB 1278, Calabar, Cross River State, Nigeria. emmanueleffa@yahoo.com.

Publication History

  1. Publication Status: Withdrawn from publication for reasons stated in the review
  2. Published Online: 5 OCT 2011

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (59K)
 
Reason for withdrawal from publication

2011, Issue 10: Review status: Current question – no update intended. Azithromycin treatments are included in the review: Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). (Thaver D, Zaidi AKM, Critchley JA, Azmatullah A, Madni SA, Bhutta ZA. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD004530. DOI: 10.1002/14651858.CD004530.pub3.)   This latter review is being updated, and will be published in late 2011. The azithrocycin review is therefore withdrawn.

The review status reports aims to help the reader understand whether the review concerns a current question, and whether it is up to date. It is a pilot project by the Cochrane Infectious Diseases Group editors to help readers and we welcome feedback. It has three components:

1. Whether the review is currently relevant. For this, we classify reviews into:

  • Historical question, where the intervention or policy has been superseded by new medical developments (such as a new drug);
  • Current question, which is still relevant to current policy or practice.

2. Whether the review is up to date: for this, we classify reviews into:

  • Up to date;
  • Update pending; or
  • No update intended.

3. An explanation of the review status.

This narrative text provides a little more additional information to explain the categories selected. To view the published versions of this article, please click the 'Other versions' tab.

View Full Article (HTML) Full (59K)